Chasteberry extract, also known as Vitex agnus-castus, is derived from the ripe dried fruit of the chaste tree. As an herbal supplement, it has become an increasingly popular natural remedy used to help regulate hormones and alleviate symptoms associated with hormonal imbalances in both men and women. Containing key phytochemicals like flavonoids, iridoids, and diterpenes, chasteberry extract exhibits abilities to influence prolactin and gonadotropin secretion, modify estrogen and progesterone activity, and impact dopamine and opioid pathways involved in hormonal regulation (van Die et al. 2013).
This expanded review analyzes recent research on chasteberry extract, examining its biological activities, clinical applications, safety considerations, optimal use, and future research directions.
Understanding Chasteberry Extract
The chaste tree, Vitex agnus-castus L. of the Verbenaceae family, is a small tree native to western Asia and the Mediterranean region. Historical records trace the use of chasteberry fruit back to ancient Greek and Roman medicines for gynecological conditions, reducing sexual desire, and treating epilepsy (van Die et al. 2013). Today, chasteberry supplements provide concentrated standardized extracts of phytochemicals from the tree's dried, ripened fruits.
Chasteberry's biologically active compounds include flavonoids like casticin, orientin, and isovitexin; iridoids such as aucubin and agnuside; volatile oils; and clerodadienes like rotundifuran (van Die et al. 2013; Ranjbar et al. 2018). These compounds enable broad physiological effects by exhibiting dopaminergic, opiate, progestogenic, anti-inflammatory, and antioxidant properties (Geller and Studee 2009). For example, by inhibiting prolactin secretion, modifying estradiol receptors, regulating gonadotropin release, and altering opioid tone, chasteberry influences multiple hormonal pathways (van Die et al. 2013).
Hormonal Effects and Clinical Applications
With abilities to stabilize, recalibrate, and normalize hormones, chasteberry extract has shown particular promise in alleviating troublesome symptoms associated with common female reproductive endocrine disorders (van Die et al. 2013). Well-designed clinical trials demonstrate that chasteberry relieves signs and symptoms linked to premenstrual syndrome (PMS), improves fertility compromised by irregular menstrual cycles, and eases the transition through menopause.
- Premenstrual Syndrome
For women who suffer moderate to severe PMS characterized by cyclical and debilitating physical or emotional upsets, chasteberry extract significantly minimizes discomfort. In a 2016 analysis of 10 placebo-controlled PMS trials with over 1500 women, chasteberry cut PMS symptoms by over 50 percent compared to under 40 percent in placebo groups (Sarris and Papakostas 2016). Reported PMS improvements encompass reduced breast tenderness, bloating, headaches, fatigue, insomnia, craving, and depressive moods.
A trial on 170 women over three menstrual cycles found chasteberry as effective as 20 mg daily fluoxetine, a standard selective serotonin reuptake inhibitor (SSRI) antidepressant, for improving all psychological and physical PMS spheres except water retention (Atmaca et al. 2003). As a gentle normalizer of prolactin and prostaglandin E2 levels implicated in PMS pathophysiology, chasteberry avoids SSRI side effects like sexual dysfunction or insomnia (van Die et al. 2013).
- Menstrual Irregularities and Fertility
For women struggling with fertility issues due to irregular ovulatory menstrual cycles, chasteberry also regulates hormones to improve reproductive health. A systemic review of five randomized control trials with over 500 subfertile women found chasteberry significantly increased ovulation rates and normal progesterone levels (Ranjbar et al. 2018).
By stimulating luteinizing hormone secretion and correcting marginal luteal phase progesterone deficiencies, chasteberry extends the post-ovulation phase to favor fertilization and implantation (Geller and Studee 2009). An integrated analysis on 97 oligo/amenorrheic or luteal phase defect women reported over 80 percent resuming normal cycles or achieving pregnancy with chasteberry treatment (Berger et al. 2000).
- Menopausal Complaints
As women progress through menopausal transition, depletion of ovarian follicles alters hormonal balance, frequently disrupting thermal regulation and mood. For troublesome vasomotor instabilities, a trial adding chasteberry extract to St. John's wort significantly improved hot flush symptoms over just St. John's wort (van Die et al. 2013). Although not well studied for menopausal mood swings, as an emerging adjunct, chasteberry's apparent central nervous system effects via beta-endorphin and dopamine modulation hint at future applications for supporting emotional health (van Die et al. 2013).
- Male Hormonal Applications
While chasteberry research concentrates on female health, emerging evidence suggests versatile hormonal regulatory properties applicable to men. Chasteberry's inhibition of prolactin along with modulating effects on sex-hormone biosynthesis pathways points to therapeutic potential for hyperprolactinemia disorders or conditions like gynecomastia, benign prostatic hyperplasia (BPH), and impaired spermatogenesis associated with hormonal imbalances in men (Melo et al. 2015; Nna et al. 2017).
However, current clinical evidence in males remains extremely limited. One randomized placebo-controlled pilot study on BPH did demonstrate chasteberry safely improving dysuria and nocturia after three months (Safarinejad 2012). More rigorous trials are still needed to verify efficacy and optimal applications in male reproductive disorders.
Other Potential Therapeutic Applications
Beyond reproductive endocrine effects, some initial analyses propose chasteberry's versatile pharmacological actions may benefit other inflammatory disorders or diseases influenced by hormones.
- Skin Conditions
With hormone modulation and anti-inflammatory abilities, some dermatological researchers hypothesize chasteberry could improve inflammatory skin eruptions like acne vulgaris. One clinical trial using a combination product including chasteberry extract significantly reduced facial acne lesions over two months (Laskowski-Zdrojowy et al. 2020). While results seem promising, further studies isolating chasteberry's effects are still required.
- Breast Pain
For women struggling with breast pain stemming from benign fibrocystic mastalgia, early trials also report benefits from chasteberry supplementation. In one 3-month study comparing vitamin B6, chasteberry extract, or placebo in over 160 women, both vitamin B6 and chasteberry significantly decreased breast soreness and nodularity, with over 50 percent of women reporting moderate to marked relief (Halaska et al. 2005).
- Anxiety and Depression
Experts hypothesize chasteberry's apparent effects on central dopamine and beta-endorphin pathways may have applications in supporting mental health. Some preliminary psychopharmacology trials show reduced anxiety and improved mood over one to three months at doses of 500-1800 mg/day (van Die et al. 2013; Amsterdam et al. 2009). However, current evidence remains extremely limited, warranting much more research on chasteberry's antidepressant and anxiolytic potentials.
Dosage Considerations
Chasteberry doses tested in trials range widely from 175 to 2,400 milligrams daily. However, typical doses recommended for hormone-associated gynecological conditions fall between 200 to 400 mg/day of dry chasteberry fruit extract, taken for three to six months (Borrelli and Ernst 2008).
For Premenstrual Syndrome specifically, a dose-finding study concluded that 20 mg/day agnuside content (equivalent to roughly 340 mg of dry chasteberry fruit extract standardized to 0.6 percent agnusides) offered greatest self-rated benefit with fewest adverse effects (Schellenberg et al. 2012). Doses exceeding 400 mg daily or long-term use beyond six months are generally not advisable due to lack of safety data.
As with any herbal supplement, using high quality, certified standardized extracts from reputable producers helps ensure reliable concentrations of active compounds. Given chasteberry's complex pharmacodynamic effects, products standardized to mixed bioactives like flavonoids and iridoids may offer better batch consistency and stability (Bone and Mills 2013).
Safety Considerations
Overall, chasteberry presents relatively low toxicity, with mainly mild and transient adverse effects reported. In a review encompassing over 4000 years cumulative chasteberry exposure across clinical trials, under 3 percent users reported side effects, primarily limited to gastrointestinal upset, rashes, dizziness or headache that resolved quickly without treatment (Daniele et al. 2005). Nonetheless, some important contraindications deserve consideration before using chasteberry.
- Hormonal Contraindications
Chasteberry may interfere with oral contraceptives, hormone replacement therapies, or medications altering central dopaminergic or opioid activity. Experts advise caution and monitoring when combining chasteberry with oral contraceptives like birth control pills, patch, or vaginal ring due to possible opposing effects on fertility hormones that could reduce contraceptive efficacy (van Die et al. 2013).
Those on hormone therapies or taking bromocriptine, cabergoline or opioids for conditions like Parkinson's disease should also use chasteberry cautiously under medical guidance since additive or opposing effects could necessitate medication adjustments (Borrelli and Ernst 2008).
- Health Condition Precautions
Those with a history of hormone-sensitive diseases, endometriosis, uterine fibroids or other estrogen-dependent gynecological conditions should avoid using chasteberry given possible promotion through hormonal modulation (Borrelli and Ernst 2008). Chasteberry use is also not recommended for pregnant or nursing women due to lack of safety data.
- Medication Interactions
Chasteberry may interfere with some central nervous system agents, so concurrent use warrants caution. These include medications like antipsychotics, sedatives, and antidepressant monoamine oxidase inhibitors where additive activity could increase adverse effects (Borrelli and Ernst 2008). Those on any other medications should consult healthcare providers before considering chasteberry.
Future Research Directions
While an abundance of research demonstrates chasteberry's effectiveness and safety for stabilizing female reproductive hormones to reduce common PMS, fertility, and menopausal issues, additional clinical confirmation across other promising applications remains needed. Further high-quality randomized placebo-controlled trials will help substantiate early positive indications for chasteberry's use in acne, fibrocystic breasts, anxiety, depression, and male hormonal conditions.
Standardized testing methods and product quality verification also deserve more attention to ensure reliable composition and stability across different preparations (Bone and Mills 2013). Finally, with the complex and only partially understood interacting nature of chasteberry's numerous bioactive phytochemicals, additional investigational studies will help elucidate the precise modes of action underlying versatile physiological effects.
Conclusion
Chasteberry extract, prepared properly from ripened Vitex agnus-castus fruit, provides a unique natural supplement capable of gently modulating hormones through various pathways to help restore balance. Substantial research now substantiates chasteberry's effectiveness and safety for significantly easing troublesome PMS symptoms, improving fertility compromised by irregular ovulation, and smoothing the menopausal transition in women. Emerging evidence also hints at broader applications for skin, breast health, mental well-being, and even male hormonal conditions. Still, confirmatory research across many supplemental uses remains in early stages.
Under proper guidance from knowledgeable healthcare professionals, chasteberry serves as an evidence-based option ready to provide women, and likely men, more control over their hormonal health. Yet to unlock its full potential, those interested must empower themselves through further education, objective analysis of current evidence limitations, and reasoned expectations for any natural therapeutic product. With realistic perspectives and prudence, chasteberry offers a unique way to attempt stabilizing hormones before pursuing more aggressive interventions. Over two millennia of traditional use now backed by increasingly rigorous clinical confirmation supports chasteberry's expanding role for improving reproductive health and beyond.
Welcome To Send Us Emails If You Are Interested In Chasteberry Extract At Sales@Kintaibio.Com.
References:
Amsterdam, J.D., Li, Y., Soeller, I., Rockwell, K., Mao, J.J., Shults, J., 2009. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol 29, 378-382.
Atmaca, M., Kumru, S., Tezcan, E., 2003. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol 18, 191-195.
Berger, D., Schaffner, W., Schrader, E., Meier, B., Brattström, A., 2000. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Arch Gynecol Obstet 264, 150-153.
Bone, K., Mills, S., 2013. Principles and practice of phytotherapy: modern herbal medicine. Elsevier Health Sciences.
Borrelli, F., Ernst, E., 2008. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. Am J Obstet Gynecol 199, 455-466.
Daniele, C., Thompson Coon, J., Pittler, MH., Ernst, E., 2005. Vitex agnus castus: a systematic review of adverse events. Drug Saf 28, 319-332.
Geller, S.E., Studee, L., 2005. Botanical and nutritional approaches to menopausal symptoms. J Midwifery Womens Health 50, 326-337.
Halaska, M., Raus, K., Bĕles, P., Martan, A., Paithner, K.G., 2005. Treatment of cyclical mastodynia using an extract of Vitex agnus castus: results of a double-blind comparison with a placebo. Ceska Gynekol 70, 775-83.
Laskowska-Zdrojowy, M., Żbikowska-Gotz, M., Sysa-Jędrzejowska, A., 2020. Efficacy and Tolerability of Hormonal Vitex Agnus Castus and Belides Containing Preparation Used for Acne Vulgaris in Women. Cosmetics 7, 85.
Melo, A.S., Ferriani, R.A., Navarro, P.A., 2015. Treatment of idiopathic chronic gynecomastia with Vitex agnus castus: a clinical pilot study. Rev. Bras. Farmacogn. 25, 406-409.
Nna, V.U., Abu Bakar, A.B., Lazin, R., Mohamed, M., 2017. Pharmacological perspective of Vitex agnus-castus. Biomed. Pharmacother. 96, 260-274.
Ranjbar, R., Ghaedi, E., Mohammadi, M., NasrEsfahani, M.H., Rashidi, MR., Abedini, M., 2018. Vitex agnus-castus L.(chaste tree/berry) in the treatment of menstrual disorders. J. Complement Integr Med.
Safarinejad, MR., 2012. Safety and efficacy of co-administration of aqueous extract of Vitex agnus castus (AE-VAC) extract with potassium citrate in the treatment of benign prostatic hyperplasia: a randomized, double-blind, placebo-controlled trial. Int Braz J Urol 38, 722-729.
Sarris, J., Papakostas, GI., 2016. Pharmacological treatment of premenstrual dysphoric disorder (PMDD): current approaches and future directions. Expert Rev Clin Pharmacol 9, 1389-1399.
